CEACAM5 and colorectal cancer: For example, such a strategy was successfully applied in various in vivo studies in mice demonstrating selective targeting of colorectal cancer using a complex of Tat conjugated to an anti-carcinoembryonic antigen (CEA) monoclonal antibody [248].